Press-release for stocks publishing date 2021 - 11 - 04 listed in the nasdaq exchange

Prices are updated after-hours

publishing date : 2021 - 11 - 04 exchanges : Nasdaq

save search

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-11-04 (Crawled : 17:00) - ir.kalvista.com
KALV | News | $10.34 -7.76% -8.41% 420K

Health Technology

| -43.19% | O: -0.44% H: 0.88% C: -0.39%
granted grant

AnaptysBio Announces Third Quarter 2021 Financial Results and Provides Pipeline Updates
Published: 2021-11-04 (Crawled : 16:00) - ir.anaptysbio.com
ANAB | $19.25 0.37% 0.36% 390K

Health Technology

| -44.13% | O: 1.48% H: 7.51% C: 5.89%
financial results results

Vaccinex, Inc. to Present at the 12th Annual Jefferies London Healthcare Conference
Published: 2021-11-04 (Crawled : 16:00) - ir.vaccinex.com
VCNX | $4.9631 -2.76% 3.5K

Health Technology

| 135.85% | O: -0.65% H: 3.5% C: -0.77%
vaccine conference

Abstracts at the Annual Meetings of the American Society of Nephrology and American College of Rheumatology Highlight Potential Value of TAVNEOS™ (avacopan)
Published: 2021-11-04 (Crawled : 16:00) - ir.chemocentryx.com
CCXI | News | $51.99 -0.04%

Health Technology

| 33.34% | O: 2.1% H: 1.46% C: -2.61%
potential avacopan

BioLineRx Announces an Oral Presentation and Three Poster Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
Published: 2021-11-04 (Crawled : 16:00) - ir.biolinerx.com
BLRX | $0.5966 -6.31% -6.74% 760K

Health Technology

| -78.37% | O: -0.35% H: 1.6% C: 0.36%
presentation ema

Assembly Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights
Published: 2021-11-04 (Crawled : 16:00) - investor.assemblybio.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M

Health Technology

| 43.35% | O: -0.28% H: 0.51% C: 0.39%
ASMB | $13.48 1.58% 1.56% 5.6K

Health Technology

| 325.24% | O: 0.0% H: 1.58% C: -1.89%
financial results results bioscience

Star Equity Holdings, Inc. to Release Third Quarter 2021 Financial Results on November 12
Published: 2021-11-04 (Crawled : 02:00) - globenewswire.com
STRR | $0.8855 1.14% 23K

Manufacturing

| -66.27% | O: -1.18% H: 5.16% C: 3.97%
financial results results

Viracta Therapeutics Announces Upcoming Oral and Poster Presentations at the 2021 American Society of Hematology Annual Meeting
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
VIRX | $0.8367 -1.31% -1.33% 55K

Manufacturing

| -86.21% | O: -0.33% H: 0.0% C: 0.0%
presentation ema

CTI BioPharma Announces Presentations at the 63rd American Society of Hematology Meeting
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
CTIC | $9.09 0.05% 11M

Health Technology

| 235.61% | O: 0.92% H: 0.0% C: 0.0%
presentation ema biopharma

Precision BioSciences Announces Two Oral Presentations Highlighting Updated Interim Data from Lead PBCAR0191 CAR T Immunotherapy
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
DTIL | $9.81 -4.11% -4.28% 34K

Health Technology

| -1.6% | O: 1.0% H: 0.0% C: 0.0%
presentation immunotherapy therapy car-t bioscience

NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K

Health Technology

| -4.75% | O: 2.29% H: 0.0% C: -2.0%
AZNCF | News | $140.3 -4.19% 1.5K

Health Technology

| 4.92% | O: 0.13% H: 0.58% C: 0.58%
GSK | News | $40.86 -0.92% -0.15% 1.7M

Health Technology

| -6.13% | O: -1.29% H: 0.0% C: 0.0%
SRPT | $124.27 6.11% 5.75% 1.3M

Health Technology

| 43.59% | O: 1.7% H: 0.0% C: 0.0%
NRBO | $3.09 2.32% 2.27% 39K

Health Technology

| 52.33% | O: 0.25% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 11.55% | O: -0.05% H: 0.0% C: 0.0%

OpGen Appoints Albert Weber as Chief Financial Officer
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
OPGN | $0.581 -5.22% -5.51% 170K

Commercial Services

| -68.89% | O: 0.56% H: 0.0% C: 0.0%

Lipocine Announces FDA Grants Fast Track Designation to LPCN 1144 for Treatment of Non-Cirrhotic NASH
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
LPCN | $4.51 -6.04% -6.43% 66K

Health Technology

| 300.0% | O: 5.41% H: 0.0% C: 0.0%
fast track designation treatment fda fast track nash granted grant designation

Keros Therapeutics to Present at the 63rd American Society of Hematology Annual Meeting and Exposition, Including Presenting Additional Data from its Phase 2 Clinical Trial Evaluating KER-050 in Patients with Myelodysplastic Syndromes
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
KROS | $56.135 1.71% 1.68% 260K

Health Technology

| 35.29% | O: -1.64% H: 0.0% C: 0.0%
ema phase 2 trial syndros

Enerflex Announces Third Quarter 2021 Financial Results and Quarterly Dividend
Published: 2021-11-04 (Crawled : 02:00) - globenewswire.com
FLEX 4 | $28.46 -0.25% -0.25% 2.6M

Electronic Technology

| 59.22% | O: 1.01% H: 1.99% C: 0.77%
financial results results

Codiak BioSciences Reports Third Quarter 2021 Financial Results and Recent Operational Progress
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
CDAK | $0.057 -55.99% -131.25% 0

Health Technology

| -99.64% | O: -1.56% H: 0.0% C: 0.0%
financial results results bioscience

Sangamo Therapeutics Reports Recent Business and Clinical Highlights and Third Quarter 2021 Financial Results
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -9.13% | O: -0.42% H: 0.0% C: 0.0%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M

Health Technology

| -94.43% | O: 7.39% H: 0.0% C: 0.0%
financial results results

Salarius Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
SLRX | $0.501 1.18% 19K

Commercial Services

| -39.62% | O: 0.05% H: 0.0% C: 0.0%
financial results results

Kura Oncology Reports Third Quarter 2021 Financial Results
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
KURA | News | $18.76 0.16% 0.16% 670K

Health Technology